New hope for kids with tough blood cancers: trial tests targeted drug combo
Disease control
Not yet recruiting
This trial is testing a new combination of three drugs—capivasertib, venetoclax, and dexamethasone—for children and young adults whose leukemia or lymphoma has come back or hasn't responded to standard treatments. The main goals are to find the safest dose and see if this combina…
Phase: PHASE1, PHASE2 • Sponsor: Princess Maxima Center for Pediatric Oncology • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC